StreetInsider.com After-Hours Movers 08/29
Tweet
Share
E-mailGet Alerts VSNT Hot Sheet
Join SI Premium – FREE
StreetInsider.com After-Hours Movers:
Versant Corporation (Nasdaq: VSNT) 24% HIGHER; reports Q3 EPS of $0.28 compared to a loss of $4.04 for the same period last year. Revenues were $3.8 million compared to $3.5 million for the same period last year.
Orthologic Corp. (Nasdaq: OLGC) 23.9% LOWER; said treatment with Chrysalin did not demonstrate benefit compared to placebo in the primary efficacy endpoint of time to removal of immobilization.
MICROS Systems (Nasdaq: MCRS) 11.8% HIGHER; reports Q3 EPS of $0.58, 7 cents better than estimates.(0.51) Revenues were $191.8 million vs. $184.58 million consensus. Sees Q1 EPS between $0.38-0.41 vs. $0.40. Sees FY07 EPS between $2.10-2.14 vs. $1.99 consensus.
Dycom Industries (NYSE: DY) 6% HIGHER; reports Q4 EPS of $0.25, 4 cents better than estimates.(0.21) Revenues were $259.9 million vs. $264.01 million consensus. Sees Q1 EPS between $0.22-0.27 vs. $0.23 consensus. Sees Q1 revenues between $250-270 million vs. $279.3 million consensus.
Sigma Designs (Nasdaq: SIGM) 5.5% HIGHER; reports Q2 revenues of $20.1 million vs. $17.85 million consensus. Company delays reporting earnings per share, citing stock option review.
ADC Telecom (Nasdaq: ADCT) 4.4% LOWER; reports Q3 EPS of $0.30, 4 cents better than estimates.(0.26) Revenues were $344 million vs. $339.59 million consensus. Sees FY EPS between $0.88-0.93 vs. consensus of $0.90. Sees FY revenues between $1.27-1.285 billion vs. $1.32 billion consensus.
Adeza Biomedical Corp. (Nasdaq: ADZA) 4.3% HIGHER; FDA panel backs Adeza drug to prevent premature births
Novell Inc. (Nasdaq: NOVL) 1.5% LOWER; reports Q3 EPS of adjusted $0.05, 2 cents better than estimates. Revenues were $241 million vs. $242.26 million consensus. Sees Q4 EPS of $0.04 vs. $0.05 consensus. Sees Q4 revenues between $246-256 million vs. $258.2 million consensus.
Versant Corporation (Nasdaq: VSNT) 24% HIGHER; reports Q3 EPS of $0.28 compared to a loss of $4.04 for the same period last year. Revenues were $3.8 million compared to $3.5 million for the same period last year.
Orthologic Corp. (Nasdaq: OLGC) 23.9% LOWER; said treatment with Chrysalin did not demonstrate benefit compared to placebo in the primary efficacy endpoint of time to removal of immobilization.
MICROS Systems (Nasdaq: MCRS) 11.8% HIGHER; reports Q3 EPS of $0.58, 7 cents better than estimates.(0.51) Revenues were $191.8 million vs. $184.58 million consensus. Sees Q1 EPS between $0.38-0.41 vs. $0.40. Sees FY07 EPS between $2.10-2.14 vs. $1.99 consensus.
Dycom Industries (NYSE: DY) 6% HIGHER; reports Q4 EPS of $0.25, 4 cents better than estimates.(0.21) Revenues were $259.9 million vs. $264.01 million consensus. Sees Q1 EPS between $0.22-0.27 vs. $0.23 consensus. Sees Q1 revenues between $250-270 million vs. $279.3 million consensus.
Sigma Designs (Nasdaq: SIGM) 5.5% HIGHER; reports Q2 revenues of $20.1 million vs. $17.85 million consensus. Company delays reporting earnings per share, citing stock option review.
ADC Telecom (Nasdaq: ADCT) 4.4% LOWER; reports Q3 EPS of $0.30, 4 cents better than estimates.(0.26) Revenues were $344 million vs. $339.59 million consensus. Sees FY EPS between $0.88-0.93 vs. consensus of $0.90. Sees FY revenues between $1.27-1.285 billion vs. $1.32 billion consensus.
Adeza Biomedical Corp. (Nasdaq: ADZA) 4.3% HIGHER; FDA panel backs Adeza drug to prevent premature births
Novell Inc. (Nasdaq: NOVL) 1.5% LOWER; reports Q3 EPS of adjusted $0.05, 2 cents better than estimates. Revenues were $241 million vs. $242.26 million consensus. Sees Q4 EPS of $0.04 vs. $0.05 consensus. Sees Q4 revenues between $246-256 million vs. $258.2 million consensus.
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Raymond James sees token pricing gap widen in August 2026
- Barclays sees music streaming growth narrow gap with Spotify
Create E-mail Alert Related Categories
General News, Special ReportsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
